VARIABLE BIOAVAILABILITY OF ORAL MERCAPTOPURINE - IS MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA BEING OPTIMALLY DELIVERED

被引：251

作者：

ZIMM, S

COLLINS, JM

RICCARDI, R

ONEILL, D

NARANG, PK

CHABNER, B

POPLACK, DG

机构：

[1] NCI,DIV CANC TREATMENT,PEDIAT BRANCH,LEUKEMIA BIOL SECT,BLDG 10,ROOM 13N240,BETHESDA,MD 20205

[2] NIH,DIV RES SERV,BIOMED ENGN & INSTRUMENTAT BRANCH,BETHESDA,MD 20205

[3] NIH,CTR CLIN,DEPT PHARM,PHARMACEUT DEV SERV,BETHESDA,MD 20205

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1983年 / 308卷 / 17期

关键词：

D O I：

10.1056/NEJM198304283081705

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1005 / 1009

页数：5

共 26 条

[1] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].

BENET, LZ ;

GALEAZZI, RL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074

[2]

BROCKMAN RW, 1963, CANCER RES, V23, P1191

[3] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES [J].

BURCHENAL, JH ;

MURPHY, ML ;

ELLISON, RR ;

SYKES, MP ;

TAN, TC ;

LEONE, LA ;

KARNOFSKY, DA ;

CRAVER, LF ;

DARGEON, HW ;

RHOADS, CP .

BLOOD, 1953, 8 (11) :965-999

[4]

DING TL, 1979, DRUG METAB DISPOS, V7, P373

[5] SIGNIFICANCE OF AZATHIOPRINE METABOLITES [J].

ELION, GB .

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1972, 65 (03) :257-+

[6]

ELION GB, 1967, FED PROC, V26, P898

[7]

ERLICHMAN C, 1980, CANCER CHEMOTH PHARM, V4, P139

[8]

FREIREICH EJ, 1963, BLOOD, V21, P699

[9]

Gibaldi M, 1975, PHARMACOKINETICS, P281

[10]

HORAKOVA K, 1974, BIOCH BIOPHYS ACTA, V336, P333

← 1 2 3 →